Dr. Veronica Christine Jones, MD

Dr. Jones practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Jones' NPI, 1558534370, was assigned on April 12, 2008. Dr. Jones graduated from Meharry Medical College School of Medicine in 2008. Dr. Jones' California license number on file is A137824.

Dr. Jones' primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Jones' primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Jones to 1 more other site, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jones practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Jones' primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Jones is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Jones' licenses on file in 2 states: California and Georgia.

Dmand AI lists mastectomy among the conditions Dr. Jones treats.

CMS data shows 381 Medicare services from Dr. Jones across 8 procedure codes in 2024, for 192 Medicare patients. Medicare paid $33,166 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Dr. Jones in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have cancer, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jones' median patient age at 65, with 98% women.

In 2024, Dr. Jones wrote 68 Medicare Part D claims for 29 patients. 100% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $79 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Jones for performance year 2024, reported as part of a group. Dr. Jones accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jones as offering telehealth. CMS counts 32 procedures of mastectomy by Dr. Jones, more than 88% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 44 papers to Dr. Jones, published from 2015 to 2025. 2019 was the busiest year, with 7. The most frequent topics are Breast Neoplasms, Black or African American and Mastectomy. Dr. Jones has published most often in Ann Surg Oncol. Dr. Jones' most frequent co-authors are Victoria Louise Seewaldt, Laura Kruper, MD and Yuman Fong, MD.

Dmand AI links Dr. Jones to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Calcinosis, Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 4 general payments to Dr. Jones from 4 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Hologic Inc paid the most, $110.

Dr. Jones graduated from Meharry Medical College School of Medicine in 2008.

Dr. Jones is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.